Use of 5-ht5-ligands in the treatment of neurodegenerative...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/519 (2006.01) A61K 45/00 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2640591

The invention relates to the use of binding partners for 5-HT5-receptors in the treatment of neuropathological and in particular neurodegenerative and/or neuropsychiatric disturbances which can occur notably in cases of cerebral ischaemia, cerebral stroke, epilepsy and attacks in general, chronic schizophrenia, other psychotic illnesses, dementia, notably Alzheimer's disease, demyelination diseases, notably multiple sclerosis, and brain tumors.

L'invention porte sur l'utilisation de partenaires de liaison des récepteurs de la 5-HT5 dans le traitement de perturbations neuropathologiques et, en particulier, de perturbations neurodégénératives et/ou neuropsychiatriques qui peuvent aussi survenir notamment en cas d'ischémie cérébrale, d'infarctus cérébral, d'épilepsie et d'attaques en général, de schizophrénie chronique, d'autres maladies psychotiques, de démence, en autres la maladie d'Alzheimer, et de maladies causées par une démyélinisation, notamment la sclérose en plaques et les tumeurs du cerveau.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of 5-ht5-ligands in the treatment of neurodegenerative... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 5-ht5-ligands in the treatment of neurodegenerative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 5-ht5-ligands in the treatment of neurodegenerative... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1975297

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.